Skinvisible, Inc. (OTCBB: SKVI) recently released its quarterly financial report for the period ending March 31, 2025. While the company is focused on innovative topical delivery systems, it continues to face challenges that are commonplace in the biotech industry.
Positive Aspects:
Stable Reven...